Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
16
×
boston blog main
clinical trials
16
×
fda
16
×
life sciences
national blog main
boston top stories
biotech
national top stories
san francisco blog main
deals
investing
new york blog main
san francisco top stories
new york top stories
san diego blog main
alnylam pharmaceuticals
drugs
patisiran
rna interference
san diego top stories
hereditary transthyretin amyloidosis
medical device
roche
startups
venture capital
akcea therapeutics
alexion pharmaceuticals
biotech ipos
boston university
drug delivery
eli lilly
eventide asset management
hepatitis b
indiana blog main
inotersen
ipo
medical devices
nonalcoholic steatohepatitis
novo nordisk
What
drug
fda
medicines
medicine
million
company
developing
ipo
pharmaceuticals
therapeutics
alnylam
approved
new
patients
raised
treat
way
ago
approval
biotechs
blood
candidate
closed
device
digital
disease
disorder
ipos
lead
medical
muscle
pharma
raises
research
rna
rnai
roche
specifically
startup
team
Language
unset
Current search:
boston
×
" clinical trials "
×
fda
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision